Podcasts about supraventricular

This week we delve into the world of electrophysiology and review a recent report from the team at Primary Children's hospital on the use of intravascular ultrasound for EP ablation procedures in children. How is this technology useful for ‘routine' ablations in kids? Are there some forms of tachycardia where its use is more important than others? How does it lower procedural time or improve efficacy? We speak with Dr. Thomas Pilcher, chief of pediatric electrophysiology at Primary Children's about his center's recent report in the use of this technology for ablation in children and those with congenital heart disease. https://doi.org/10.1093/europace/euae047

Contributor: Travis Barlock MD Educational Pearls: Wide-complex tachycardia is defined as a heart rate > 100 BPM with a QRS width > 120 milliseconds Wide-complex tachycardia of supraventricular origin is known as SVT with aberrancy Aberrancy is due to bundle branch blocks Mostly benign Treated with adenosine or diltiazem Wide-complex tachycardia of ventricular origin is also known as VTach Originates from ventricular myocytes, which are poor inherent pacemakers Dangerous rhythm that can lead to death Treated with amiodarone or lidocaine 80% of wide-complex tachycardias are VTach 90% likelihood for patients with a history of coronary artery disease In assessing a wide-complex tachycardia, it is best to treat it as a presumed ventricular tachycardia Treating SVT with amiodarone or lidocaine does no harm  However, treating VTach with adenosine or diltiazem may worsen the condition References 1. Littmann L, Olson EG, Gibbs MA. Initial evaluation and management of wide-complex tachycardia: A simplified and practical approach. Am J Emerg Med. 2019;37(7):1340-1345. doi:https://doi.org/10.1016/j.ajem.2019.04.027 2. Viskin S, Chorin E, Viskin D, Hochstadt A, Schwartz AL, Rosso R. Polymorphic Ventricular Tachycardia: Terminology, Mechanism, Diagnosis, and Emergency Therapy. Circulation. 2021;144(10):823-839. doi:10.1161/CIRCULATIONAHA.121.055783 3. Williams SE, O'Neill M, Kotadia ID. Supraventricular tachycardia: An overview of diagnosis and management. Clin Med J R Coll Physicians London. 2020;20(1):43-47. doi:10.7861/clinmed.cme.20.1.3 Summarized by Jorge Chalit, OMSIII | Edited by Meg Joyce & Jorge Chalit

ECG characteristics of supraventricular tachycardia (SVT) vs. sinus tachycardia. Signs & symptoms that indicate a patient is unstable. Delivery of a synchronized shock for the treatment of unstable SVT using a biphasic vs monophasic defibrillator. Consideration for team safety while performing synchronized cardioversion. Actions to take immediately if an unstable patient we've cardioverted goes into a pulseless rhythm. Management of stable patients in SVT.For more on narrow complex tachycardias, check out the pod resource page at passacls.com.Connect with me:Website: https://passacls.com@PassACLS on X (formally known as Twitter)@Pass-ACLS-Podcast on LinkedInGive back - buy Paul a bubble tea hereGood luck with your ACLS class!

Commentary by Ratika Parkash

In our latest episode, we venture into the heart of cardiology innovation, exploring groundbreaking studies that are reshaping how we approach common cardiovascular conditions.   STUDY #1: Our journey begins with a Lancet paper that looks at a potential alternative for treating supraventricular tachycardias (SVTs). Imagine a world where the distress of SVTs can be alleviated without ablation, a rush to the emergency department or the complexities of intravenous therapy. An intranasal medication might be the key, offering a beacon of hope for patients seeking simpler, yet effective solutions. But how effective is this approach, and what does it mean for the future of SVT management? Stambler, BS, Camm, AJ, Alings, M, et al. 2023. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): A multicentre, randomized trial. Lancet. 10396: 118–128. (https://doi.org/10.1016/S0140-6736(23)00776-6)   STUDY #2: Transitioning to the realm of antiplatelet therapy, we confront the longstanding question of P2Y12 inhibitors versus aspirin. Will these new findings tilt the balance and shift our approach to secondary coronary prevention? The nuances of this study prompt a deeper reflection on patient-centric care and the economics of new-generation medications.  Gragnano, F, Cao, D, Pirondini, L, et al. 2023. P2Y12 inhibitor or aspirin monotherapy for secondary prevention of coronary events. J Am Coll Cardiol. 2: 89–105. (https://doi.org/10.1016/j.jacc.2023.04.051)   STUDY #3: Lastly, we explore the potential of bempedoic acid in the landscape of cholesterol management, particularly for patients who are intolerant to statins. With cardiovascular diseases looming as a pervasive threat, the quest for alternative treatments is critical. We see if bempedoic acid could play a potential role in reducing major cardiovascular events, either alongside, or perhaps in lieu of, traditional statin therapy. Nissen, SE, Menon, V, Nicholls, SJ, et al. 2023. Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients. JAMA. 2: 131–140. (https://doi.org/10.1001/jama.2023.9696) Kazi, DS. 2023. Bempedoic acid for high-risk primary prevention of cardiovascular disease: Not a statin substitute but a good plan B. JAMA. 2: 123–125. (https://doi.org/10.1001/jama.2023.9854)   Each study we discuss brings its own set of questions, implications, and possibilities for the future of cardiology. From the practicalities of new drug administrations to the cost and effectiveness of established therapies, this episode will get you up to speed!  For show notes, visit us at https://www.medmastery.com/podcasts/cardiology-podcast.

Paroxysmal supraventricular tachycardia (PSVT) is a sudden-onset tachyarrhythmia that can cause palpitations, chest discomfort, and dyspnea. JAMA Associate Editor David Simel, MD, MHS, discusses the diagnosis and treatment of patients with PSVT with author Paul Zei, MD, of Harvard University. Related Content: Diagnosis and Management of Paroxysmal Supraventricular Tachycardia Modified Valsalva Maneuver (video) Carotid Sinus Massage (video)

ECG characteristics of supraventricular tachycardia (SVT) vs. sinus tachycardia. Signs & symptoms that indicate a patient is unstable. Delivery of a synchronized shock for the treatment of unstable SVT using a biphasic vs monophasic defibrillator. Consideration for team safety while performing synchronized cardioversion. Actions to take immediately if an unstable patient we've cardioverted goes into a pulseless rhythm. Management of stable patients in SVT. For more on narrow complex tachycardias, check out the pod resource page at passacls.com.Connect with me:Website: https://passacls.com@PassACLS on X (formally known as Twitter)@Pass-ACLS-Podcast on LinkedInGive back via PayPal Good luck with your ACLS class!

In this podcast, Dr Lip and Dr Stambler discuss the RAPID trial (NCT03464019), which was a phase 3 study that evaluated the safety and efficacy of etripamil in terminating PSVT episodes using a repeat-dosing regimen. RAPID was a multicenter, randomized trial that enrolled adults with electrocardiograph (ECG)-documented PSVT episodes lasting ≥ 20 min. This podcast is published open access in Cardiology and Therapy and is fully citeable. You can access the original published podcast article through the Cardiology and Therapy website and by using this link: [https://link.springer.com/article/10.1007/s40119-023-00335-4]. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The material in this podcast is included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.  

ECG characteristics of supraventricular tachycardia (SVT) vs. sinus tachycardia. Signs & symptoms that indicate a patient is unstable. Delivery of a synchronized shock for the treatment of unstable SVT using a biphasic vs monophasic defibrillator. Consideration for team safety while performing synchronized cardioversion. Actions to take immediately if an unstable patient we've cardioverted goes into a pulseless rhythm. Management of stable patients in SVT. For more on narrow complex tachycardias, check out the pod resource page at passacls.com.**American Cancer Society (ACS) Fundraiser This is the fifth year that I'm participating in Men Wear Pink to increase breast cancer awareness and raise money for the American Cancer Society's life-saving mission.I hope you'll consider contributing.Every donation makes a difference in the fight against breast cancer! Paul Taylor's ACS FundraiserTHANK YOU! Connect with me:Website: https://passacls.com@PassACLS on Twitter@Pass-ACLS-Podcast on LinkedInGive back & support the show:via PayPal Good luck with your ACLS class!10 Halloween Poisoning Prevention Tips from Ohio Pharmacist, Kim Newlove of The Pharmacists Voice Podcast

Under ESC 2023 intervjuade vi Alexandra Måneheim, ST-läkare, Klinisk Fysiologi & Doktorand, Kardiovaskulär Epidemiologi, Lunds Universitet, om studien; How reliable are single day electrocardiogram measurements to detect excessive supraventricular ectopic activity. PP-ELI-SWE-2805

ECG characteristics of supraventricular tachycardia (SVT) vs. sinus tachycardia. Signs & symptoms that indicate a patient is unstable. Delivery of a synchronized shock for the treatment of unstable SVT using a biphasic vs monophasic defibrillator. Consideration for team safety while performing synchronized cardioversion. Actions to take immediately if an unstable patient we've cardioverted goes into a pulseless rhythm. Management of stable patients in SVT. For more on narrow complex tachycardias, check out the pod resource page at passacls.com.Connect with me:Website: https://passacls.com@PassACLS on Twitter@Pass-ACLS-Podcast on LinkedInGive back & support the show:via PayPal Good luck with your ACLS class!

ECG characteristics of supraventricular tachycardia (SVT) vs. sinus tachycardia. Signs & symptoms that indicate a patient is unstable. Delivery of a synchronized shock for the treatment of unstable SVT using a biphasic vs monophasic defibrillator. Consideration for team safety while performing synchronized cardioversion. Actions to take immediately if an unstable patient we've cardioverted goes into a pulseless rhythm. Management of stable patients in SVT. For more on narrow complex tachycardias, check out the pod resource page at passacls.com.Connect with me:Website: https://passacls.com@PassACLS on Twitter@Pass-ACLS-Podcast on LinkedInGive back & support the show:via PayPal Good luck with your ACLS class!

This episode covers supraventricular tachycardia (SVT).Written notes can be found at https://zerotofinals.com/medicine/cardiology/svt/ or in the cardiology section of the 2nd edition of the Zero to Finals medicine book.The audio in the episode was expertly edited by Harry Watchman.

ECG characteristics of supraventricular tachycardia (SVT) vs. sinus tachycardia. Signs & symptoms that indicate a patient is unstable. Delivery of a synchronized shock for the treatment of unstable SVT using a biphasic vs monophasic defibrillator. Consideration for team safety while performing synchronized cardioversion. Actions to take immediately if an unstable patient we've cardioverted goes into a pulseless rhythm. Management of stable patients in SVT. For more on narrow complex tachycardias, check out the pod resource page at passacls.com.Connect with me:Website: https://passacls.com@PassACLS on Twitter@Pass-ACLS-Podcast on LinkedInGive back & support the show:via PayPal Good luck with your ACLS class!

Cardio: 6. Harry and Dan talk about SVTs, recognising them clinically and their management. This episode also covers Wolff-Parkinson-White syndrome. This episode was vetted by a Consultant Cardiologist (who wishes to remain anonymous) at the Royal Brompton & Harefield NHS Trust, London. Links: An example of an ECG showing SVT SVT example 1a https://litfl.com/supraventricular-tachycardia-svt-ecg-library/ An example of an ECG showing WPW pattern Example 2 https://litfl.com/pre-excitation-syndromes-ecg-library/ Modified Valsava technique from the REVERT Trial link https://www.youtube.com/watch?v=8DIRiOA_OsA Resus council adult tachycardia algorithim (2021) https://www.resus.org.uk/sites/default/files/2021-04/Tachycardia%20Algorithm%202021.pdf Key resource used (but frankly, this provides detail far beyond what is expected for medical school): Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia: The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020;41(5):655-720. doi:10.1093/eurheartj/ehz467

ECG characteristics of supraventricular tachycardia (SVT) vs. sinus tachycardia. Signs & symptoms that indicate a patient is unstable. Delivery of a synchronized shock for the treatment of unstable SVT using a biphasic vs monophasic defibrillator.Consideration for team safety while performing synchronized cardioversion.Management of stable patients in SVT.For more on narrow complex tachycardias, check out the pod resource page at passacls.com.Connect with me:Website: https://passacls.com@PassACLS on Twitter@Pass-ACLS-Podcast on LinkedInGive back & support the show:via PayPal Good luck with your ACLS class!

1.26 Supraventricular Tachycardia   Cardiovascular system review for the USMLE Step 1 exam.

CME credits: 1.25 Valid until: 23-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/self-administered-etripamil-for-termination-of-spontaneous-paroxysmal-supraventricular-tachycardia-primary-analysis-from-the-rapid-study/14430/ In this program, expert faculty review and discuss real-world applications of the latest, practice-changing data across different therapeutic areas within cardiovascular medicine presented at the American Heart Association Scientific Session 2022.

ECG characteristics of supraventricular tachycardia (SVT) vs. sinus tachycardia. Signs & symptoms that indicate a patient is unstable. Treatment of unstable SVT using a biphasic vs monophasic defibrillator. Consideration for team safety while performing synchronized cardioversion. Stable patients in SVT.For more on narrow complex tachycardias, check out the pod resource page at passacls.com.Connect with me:Website: https://passacls.com@PassACLS on Twitter@Pass-ACLS-Podcast on LinkedInGood luck with your ACLS class!

Commentary by Dr. Valentin Fuster

ECG characteristics of supraventricular tachycardia (SVT) vs. sinus tachycardia. Signs & symptoms that indicate a patient is unstable. Treatment of unstable SVT using a biphasic vs monophasic defibrillator. Consideration for team safety while performing synchronized cardioversion. Treatment of stable patients in SVT. Not ACLS but something I'm just as passionate about is the battle against cancer. This is the fourth year that I'm participating in Real Men Wear Pink and have pledged to wear pink every day in October to: raise awareness of breast cancer; connect with breast cancer patients & survivors; and raise money for the American Cancer Society's life-saving mission. Chances are that you know someone that has fought breast cancer or have lost a loved one to this insidious disease. Please consider making a donation to my American Cancer Society fundraiser and make a difference in the fight against breast cancer. Donations go directly to the American Cancer Society and can be made anonymously to protect your privacy. http://main.acsevents.org/goto/paultaylor (Paul Taylor's Real Men Wear Pink ACS Fundraiser) THANK YOU! Connect with me: Website:  https://passacls.com (https://passacls.com) https://twitter.com/PassACLS (@PassACLS) on Twitter https://www.linkedin.com/company/pass-acls-podcast/ (@Pass-ACLS-Podcast) on LinkedIn Good luck with your ACLS class!

In this episode, we review the high-yield topic of Supraventricular Tachycardia from the Cardiovascular section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets

Chegou Um Paciente Com Taquicardia Supraventricular...e Agora by Cardiopapers

Adult patients with a heart rate over 100 beats/min are tachycardic. If a patient's heart rate is greater than 150 with narrow complex QRS on the ECG, the patient is in a supraventricular tachycardia (SVT). Characteristics of SVT on the ECG. Signs and symptoms that indicate a stable vs unstable patients in SVT. Treatment of unstable patients in SVT is a synchronized shock or cardioversion. Safety tip for safe cardioversion. Connect with me: Website:  https://passacls.com (https://passacls.com) https://twitter.com/PassACLS (@PassACLS) on Twitter https://www.linkedin.com/company/pass-acls-podcast/ (@Pass-ACLS-Podcast) on LinkedIn Good luck with your ACLS class! If you're a Michigan ACLS provider and will be attending the Save MI Heart meeting, say hello. I'd love to get your feedback and suggestions to improve the show. https://www.savemiheart.org/ (https://www.savemiheart.org/)

In this episode, Grace and Madison talk about supraventricular tachycardia (SVT) which is near and dear to Grace's heart.

Supraventricular tachycardia can present very stable, but this patient rapidly declined.  In this episode we explain what exactly is happening with SVT, and go through all the different treatment modalities from vagal maneuvers, to medications, to synchronized cardioversion.

Gui, Joanne e Kaue debatem sobre o manejo de taquiarritmias. Abordamos alguns conceitos de eletrocardiograma, conversamos sobre o passo a passo da avaliação de taquiarritmias com QRS estreito e largo, além de cardioversão elétrica e as drogas possíveis. Esse episódio foi em parceria com o Whitebook A medfriday vai começar em breve! Acesso o site pra ficar informado! https://medfriday.pebmed.com.br/?utm_source=podcast&utm_medium=cpc&utm_campaign=medfriday-comercial-2021-tdc&utm_content=tdc Referências: Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J 2020; 41:655. Kalbfleisch SJ, el-Atassi R, Calkins H, et al. Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram. J Am Coll Cardiol 1993; 21:85. Brugada P, Brugada J, Mont L, et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991; 83:1649. Vereckei A, Duray G, Szénási G, et al. Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia. Eur Heart J 2007; 28:589. Kaiser E, Darrieux FC, Barbosa SA, et al. Differential diagnosis of wide QRS tachycardias: comparison of two electrocardiographic algorithms. Europace 2015; 17:1422. Ganz LI, Friedman PL. Supraventricular tachycardia. N Engl J Med 1995; 332:162. Katritsis DG, Josephson ME. Differential diagnosis of regular, narrow-QRS tachycardias. Heart Rhythm 2015; 12:1667. Link MS. Clinical practice. Evaluation and initial treatment of supraventricular tachycardia. N Engl J Med 2012; 367:1438. Smith GD, Dyson K, Taylor D, et al. Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia. Cochrane Database Syst Rev 2013; :CD009502. Appelboam A et al. Postural Modification to the Standard Valsalva Manoeuvre for Emergency Treatment of Supraventricular Tachycardias (REVERT): A Randomised Controlled Trial. Lancet 2015.

Follow Tori on Facebook and Instagram @torijoygeiger. You can also join her Facebook Group, the Tori Joy Geiger Victory Tribe. You can purchase her book, "From Vulnerable to Victorious", on Amazon or on her website, torijoygeiger.com.Check out our website, myimmunesystempod.com, where you can get in contact with Chelsey, listen to old episodes, learn about the RA Warrior Group, buy a signed copy of Chelsey's book, and apply to be a guest on the show.Don't forget to rate and review the show, and follow us on Instagram and Facebook @myimmunesystempod***Any information discussed in this podcast is strictly my opinion and those of my guests and are for informational purposes only. We are speaking from our personal experiences and you should always consult with your doctor or medical team.

Christina Mae Watson went on her honeymoon with her new husband Gabe to scuba dive the Great Barrier Reef in Australia. She had a heart condition but she got her diving certificate and joined her husband in smaller dives. This would be her first time diving in the open ocean. Two minutes after she got in the water with Gabe, Gabe came to the surface and asked for help retrieving Tina, she had lost consciousness and sank to the bottom of the ocean. She did not survive. Gabe was convicted of manslaughter because he had failed to rescue her however some people believe he actually was the one that caused her air supply to be cut off in the first place. What are your thoughts? Contact me at CrimeCastlePod on Twitter or email me at crimecastlepod@gmail.comSources:https://en.wikipedia.org/wiki/Death_of_Tina_Watsonhttps://www.theguardian.com/world/2009/jun/05/man-guilty-manslaughter-wife-scuba-deathhttps://en.wikipedia.org/wiki/Supraventricular_tachycardiahttps://en.wikipedia.org/wiki/Paroxysmal_supraventricular_tachycardia

Dr. Glauco Bonato fala sobre a investigação a ser feita no paciente com palpitação.

Commentary by Drs. Maully Shah

Commentary by Dr. Julia Grapsa and Antonio Sorgente

This is unequivocally the last topic I want to be writing an article about, but here I am. Acceptance is a real MOTHER! Up, at the crack of dawn early on my second Saturday morning, to share a topic that's one of my least favorite to talk about, let alone acknowledge and accept. I especially have a hard time sharing it with others. My reason for sharing is because I don't have the energy to explain some of my actions in recent months, and I feel I owe it to my friends, family, followers, and readers so they understand my actions better. I have had to back out of some things that I previously committed to. I have had to clear my plate of all items that are not 100% needed and necessary. I've had to walk away from communities, commitments, and even people to release some things from my life that we're no longer adding to it the way I needed them to. The other part is me stepping out of denial that this is even a “thing” for me and stepping into the light that sharing this IS a real thing, and I hope a piece of my journey might help someone else. This episode is also available as a blog post: http://pamelakaranova.com/2021/09/01/learning-to-live-and-hike-with-supraventricular-tachycardia-svt/ --- Send in a voice message: https://anchor.fm/pamela-karanova/message Support this podcast: https://anchor.fm/pamela-karanova/support

In this episode, we tackle a group of tachyarrhythmias known as paroxysmal supraventricular tachycardias, or pSVTs. This family includes atrioventricular nodal re-entry tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT), and is related to the Wolff-Parkinson-White syndrome. Learn how these arrhythmias come about in the first place, then how to recognize them and ultimately treat them. There's more to pSVTs than the buzzwords; come hear for yourself!

Written By: Caleb Dusdal Peer Review: Thomsen D'hont https://thegenerehlist.ca/2020/11/01/episode-two-acls-part-i/www.thegenerehlist.ca 1. Keep up to date with ACLS recommendations 2. Know how to recognize and defibrillate a patient with Ventricular Fibrillation, or ventricular tachycardia that is either pulseless or symptomatic. 3. Be able to diagnose worrysome arrhythmias such as: a. Ventricular tachycardia b. Ventricular fibrillation c. Supraventricular tachycardia d. Atrial fibrillation e. Second and third-degree heart block 4. Know when to suspect a few specific causes of arrhythmias, even before confirmatory testing. a. Hyperkalemia b. Digoxin toxicity c. Cocaine intoxication 5. Know how and when to ensure adequate ventilation and secure the airway in a timely manner 6. In patients who do require resuscitation, you want to be able to assess the context to help decide when stopping resuscitation is the most appropriate decision. 7. Patients who arrest or are at risk of arresting, with serious medical problems or end stage disease, you need to know how and when to discuss code status and making end-of-life decisions 8. Ensure you attend to the family members as well, both during and after resuscitation the patient. Eg. Counselling availability, whether or not they are present in the code, etc. 9. In paediatric resuscitation, know what resources you can use to determine the correct drug dosing and tube sizes. As well as how to use these.  

Listen to my story --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/noobie-stories/message Support this podcast: https://anchor.fm/noobie-stories/support

In this episode we cover the correct pronunciation of Bundle of His, as well as some other stuff about SVTs

Cassie Davis from Melfort, Saskatchewan shares her two pregnancy and birth stories.  She was diagnosed with a heart condition called SVT with both pregnancies and shares what it was like navigating pregnancy and birth under those circumstances.  Both births were in hospital with epidurals for pain management in an effort to keep her heart-rate down.

9.- Circulatorias

Welcome To The MedFlashGo Podcast. This Is Your Daily 4 Minutes Or Less Rapid Review for medical students. Topics are based on medical board examinations including USMLE, COMLEX, And Shelf Exams. We release a new episode every weekday! In this question of the day, Sean asks students to identify the correct treatment for SVT. These questions are powered by MedFlashGo The First Voice-based interactive medical question bank currently available on Alexa. This tool allows medical students to study medical topics and be interactively tested without the use of a screen. You can study on your couch, in your car, and on the move without the use of a screen. To get access to the free audio-interactive question bank, click here or go to your Alexa application and search medflashgo In the skills section. To learn more details go to medflashgo.com and check out our frequently asked questions section. Please know that these questions were creatively designed by medical students and physicians for the purpose of education and do not replace health information given from your health professionals. We have tried our best to make sure the information is accurate please, so please let us know if you find any errors and we will be sure to correct them. --- Send in a voice message: https://anchor.fm/medflashgo/message

In MRCPCH theory exam

Get into a rhythm with our coverage on SVTs! In this episode we delve into the core elements of assessment and management, covering: Definition (0:36) Triggers and features (1:36) Management (8:20) Investigations and follow up (19:09) Summary and sign off (23:06)

Course: Cardiac Dysrhythmias Part 1 - Supraventricular Tachycardia Course Director: Tony R Tarchichi M.D.  - Assistant Professor in Dept of Pediatrics Course Director: Gaurav Arora M.D. Associate Professor in the Dept of Pediatrics   Disclosures: None This Podcast series was created for Pediatric Hospitalists or those healthcare professionals who take care of hospitalized children.  This episode is Cardiac Dysrhythmias Part 1 - Supraventricular Tachycardia. As always there is free CME credit of up to 1 AMA category 1 for listening to this podcast and going to the Univ of Pitt site. See the link below.  ______________________________________________________ Objectives: Upon completion of this activity, participants will be able to: Review the presentation of Supraventricular Tachycardia in different pediatric age ranges. Review the definition and mechanism for Supraventricular Tachycardia in pediatrics.  Review the treatment of Supraventricular Tachycardia in pediatrics.  ______________________________________________________ Released:  11/21/2019, Reviewed 11/21/2019, Expire: 11/21/2020 If you are new to the Internet-based Studies in Education and Research (ISER) website (which is how you will get your CME credit), you will first need to create an account: Step 1. Create an Account https://www.hsconnect.pitt.edu/HSC/home/create-account.do If you have used the ISER website in the past, you can click on the link below and then log onto in order to complete the evaluation for this training: Step 2. To access the test for CME credit: https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=21153 Accreditation Statement: The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this enduring material for a maximum of  (1)  AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Please bear with me as this is a work in progress*** I suffer from atrial fibrillation as well as supraventricular tachycardia and I am a survivor of multiple strokes -  all due to PTSD, stress and life behaviors that were not good for me at all. I am really excited to share my experiences. I also want to share what I did after I learned more about what happened to me in order to curb my stress anxiety and how I turned my dire health situation into the life I have always wanted.   View my products at www.luxiouslemon.com

We all remember years ago when we took ACLS for the first time, once we got to the section on SVT, they would always say that we should “try vagal maneuvers” before moving to chemical conversion. Today we are going to review diagnosing SVT and re-examine all of the modalities available to those who see these patients present to the ED and Urgent Care. Supraventricular tachycardia (SVT) is a common tachydysrhythmia in young, otherwise healthy patients and can present in any acute care setting.  Drs. Little and Kalnow from the EM Over Easy Podcast (https://emovereasy.com/) sit down with Mizuho to discuss the diagnosis and management of SVT.    There is so much more to Urgent Care RAP each month? Click Here to hear more of what you need to be ready each day and we'll toss in 42 CME hours per year to boot.

Dr. Zaven Sargsyan joins the CPSolvers to share his approach to supraventricular tachycardia

We have previously podcasted on tachyarrythmias (Episode 34 Tachyarrhythmias), but in this episode, we focus specifically on the treatment of supraventricular tachycardia  (SVT),  specifically paroxysmal SVT. We discuss the treatment options of adenosine and calcium channel blockers, weighing in with the evidence, the guidelines, and some opinion. Thanks for listening! Lauren Westafer and Jeremy Faust   Thanks to Figure 1 for supporting this episode. We do not make money off of this podcast, this support is just for operational costs associated with the podcast.

Podcast summary of articles from the July 2018 edition of Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include pediatric asthma, troponins in SVT, naloxone use, hyperkalemia treatment, and board review on aortic stenosis and rocky mountain spotted fever.  Guest speaker is Dr. Adam Bates.

Dr Paul Wang:                   Welcome to the monthly podcast, On the Beat for Circulation: Arrhythmia and Electrophysiology. I'm Dr Paul Wang, Editor-in-Chief, with some of the key highlights from this month's issue. In our first paper this month, Shaan Khurshid and associates determine the frequency of rhythm abnormalities in 502,627 adults in the UK Biobank, a national prospective cohort. They found that 2.35% had a baseline rhythm abnormality. The prevalence increased with age, with 4.84% of individuals aged 65 to 73 years having rhythm abnormalities. During over three million person- years of follow up, nearly 16,000 new rhythm abnormalities were detected. Atrial fibrillation was the most frequent with three per thousand person-years. Bradyarrhythmia with almost one per thousand person-years. Conduction system disease is about one per one thousand years. Supraventricular and ventricular arrhythmias, each about one half per one thousand person-years. Older age was associated with a hazard ratio of 2.35 for each 10 year increase. Male sex, hypertension, chronic kidney disease and heart failure were all associated with new rhythm abnormalities. In our next paper, Fabien Squara and associates evaluated a method of determining the septal or free wall positioning of pacemaker or ICD leads during fluoroscopy. They compared in 50 patients a classical approach using posterior anterior, right anterior oblique 30 degrees, and left anterior oblique 40 degrees fluoroscopic imaging’s to 50 patients undergoing an individualized left anterior oblique or LAO approach. This individualized LAO approach view provided a true view of the interventricular septum. This angle was defined by the degree of LAO that allowed the perfect superimposition of the RV apex, using the tip of the right ventricular lead, temporarily placed at the apex, and one of the superior vena cava, inferior vena cava access using a guide wire. Transthoracic echo was used to confirm position of the right ventricular lead. Septal, or free wall, right ventricular lead positioning was correctly identified in 96% of patients in the individualized group, versus 76% in the classical group. P equals 0.004. For septal lead positioning fluoroscopy had 100% sensitivity, and an 89.5 specificity in an individualized group, versus 91.4% sensitivity, and a 40% specificity in the classical group. In our next paper, Elsayed Soliman and associates examined the lifetime risk of atrial fibrillation based on race and socioeconomic status. In the atherosclerosis risk in communities, ARIC, cohort, of 15,343 participants without atrial fibrillation, patients were recruited in 1987 to 1989, when they were 45 to 64 years of age, and followed through 2014. The authors identify 2,760 atrial fibrillation cases during a mean follow up of 21 years. The authors found that the lifetime risk of atrial fibrillation in the ARIC cohort was approximately one in three among whites, and one in five among African Americans. And, the socioeconomic status was inversely associated with cumulative incidents of atrial fibrillation before the last decades of life. In our next paper, Jonathan Steinberg and associates sought to determine the impact of atrial fibrillation episode duration threshold on atrial fibrillation incidents and burden in pacemaker patients in a prospective registry. In 615 pacemaker patients was device detected atrial fibrillation over a mean follow up of 3.7 years, 599 had one or more atrial fibrillation episodes of 30 seconds duration, with a mean number of 22 episodes. At 12 months, freedom from atrial fibrillation ranged from 25.5% to 73.1%, based on a duration threshold from 30 seconds up to 24 hours. Of patients with a first episode of 30 seconds to two minutes, 35.8% were free from subsequent episodes greater than two minutes at 180 days. The mean atrial fibrillation burden of 0.2% for patients with first episodes between 30 seconds and 3.8 hours, was significantly less than the 9.5% burden for those with greater than 3.8 hours. The authors concluded that small differences in atrial fibrillation episode duration definition can significantly affect the perceived incidents of atrial fibrillation impact reported outcomes, including atrial fibrillation success. An initial atrial fibrillation episode of 30 seconds does not predict clinically meaningful atrial fibrillation burden. In the next paper, Hongwu Chen and Linsheng Shi and associates examined the distinct electrophysiologic features of bundle branch reentrant ventricular tachycardia in patients without structural heart disease. They described nine patients, mean age 29.6 years, with normal left ventricular function and bundle branch reentrant ventricular tachycardia, with a right bundle branch block pattern in one patient, and left bundle branch block patterns in nine patients. In all left bundle branch block pattern ventricular tachycardia, the mean ventricular tachycardia cycling was 329.3 milliseconds, and the median HV interval during tachycardia was longer than that of baseline, 78 versus 71 milliseconds. The H to right bundle interval during ventricular tachycardia was slightly shorter, however, the right bundle to ventricular interval was markedly longer than that during sinus rhythm, 50 versus 30 milliseconds. In six patients with three dimensional mapping of the left ventricle, a slow anterograde, or retrograde conduction over the left His-Purkinje system with normal myocardial voltage was identified. In addition, Purkinje related ventricular tachycardias were also induced in five patients. Ablation was applied to the distal left bundle branch block in patients with baseline left bundle branch block, and in one narrow QRS patient with sustained Purkinje related ventricular tachycardia, while right bundle branch was targeted in other patients. During a mean follow up at 31.4 months, frequent premature ventricular contractions occurred in one patient, and new ventricular tachycardia developed in the other patient. In the next paper, Michel Haissaguerre and associates examined detailed mapping in 24 patients who survived idiopathic ventricular fibrillation. They used multi-electrode body surface recordings to identify the drivers maintaining ventricular fibrillation, and analyze electrograms in the driver regions, using endocardial and epicardial catheter mapping during sinus rhythm. Ventricular fibrillation occurred spontaneous in three patients, and was induced in 16, while VF was non-inducible in five. Ventricular fibrillation mapping demonstrated reentrant and focal activities, 87% and 13% respectively. The activities were dominant in one ventricle in nine patients, while they were biventricular in the others. During sinus rhythm, areas of abnormal electrograms were identified in 15 out of 24 patients, or 62.5%, revealing localized structural alterations, in the right ventricle in 11, the left ventricle in one, in both in three. They covered a limited surface, 13 centimeters squared, representing 5% of the total surface, and recorded predominantly on the epicardium. 76% of these areas were co-located with ventricular fibrillation drivers. In nine patients without structural alterations, the authors observed a high incidence of Purkinje triggers, seven out of nine, versus four out of 15. Catheter ablation resulted in arrhythmia-free outcomes in 15 out of 18 patients at a 17 month follow up. In our next paper, David Spar and associates describe the effectiveness, safety, and compliance of the wearable cardioverter defibrillator in the identification and treatment of life-threatening ventricular arrhythmias in all US pediatric patients who wore a wearable defibrillator from 2009 to 2016, ages less than 18 years. The 455 patients had a median age of 15 years, median duration of wearable cardioverter defibrillator use of 33 days, and median patient wear time of 20.6 hours per day. The study population was divided into two groups, 63 patients with an ICD problem, or 392 patients without an ICD problem. The wear time was greater than 20 hours in both groups. There were seven deaths, or 1.5%. All patients were not wearing the wearable cardioverter defibrillator at the time of death. Eight patients, 1.8%, received at least one wearable cardioverter defibrillator shock treatment. Of the six patients who had appropriate therapy, there were seven episodes of either polymorphic ventricular tachycardia, or ventricular fibrillation, with a total of 13 treatments delivered. All episodes were successfully converted, and the patient survived. In our next paper, Marc Lemoine and associates used human-induced pluripotential stem cell-derived cardiomyocytes to examine differences in repolarization reserve. The authors compared the contribution of IKs and IKr on action potential durations in human left ventricular tissue, and the human induced pluripotential stem cell derived cardiomyocytes, or IPS-derived engineered heart tissue. They found that the IPS-derived heart tissue showed spontaneous diastolic depolarization in action potential duration, which were sensitive to low concentrations of Ivabradine. IKr block by E-4031 prolonged action potential duration 90 with similar EC50 in both the IPS-derived heart tissue and the human left ventricular tissue. But a larger effect size in the IPS-derived heart tissue, 281 milliseconds versus 110 milliseconds, in the human left ventricular tissue. While IKr block alone evoked early after depolarizations, it triggered activity in 50% of the IPS-derived heart tissue. Slow pacing reduced extracellular potassium blocking of IKr, IKs and IK1 were necessary to induce early after depolarizations in human left ventricular tissue. In accordance with their clinical safety, Moxifloxacin and Verapamil did not induce EADs in IPS-derived heart tissue. In both IPS-derived heart tissue and human left ventricular tissue, IKs block by HMR 1556 prolonged action potential duration 90 slightly in the combined presence of E-4031 and isoprenaline. In our next paper, Elizabeth Saarel and associates sought to obtain contemporary digital ECG measurements in healthy children from North America to evaluate the effects of sex and race, and to compare the results to commonly published data sets, using 2400 digital ECGs, collected for children less than 18 years of age with normal electrocardiograms at 19 centers in the pediatric heart network. The authors found that the QTc in lead II was greater for females compared to males for age groups three years or older, for whites compared to African Americans, for ages 12 years or older. The R wave amplitude in V6 was greater for males compared to females for age groups 12 years and greater; for African Americans compared to white or other race categories for age groups three years or greater; and greater compared to commonly used public data set groups for ages 12 years and greater. In our next paper, Pyotr Platonov and associates examined T-wave morphology as a possible predictor of cardiac events in patients with type 2 long QT syndrome mutation carriers with normal QTc intervals. The authors compared 154 LQT2 mutation carriers with QTc less than 360 milliseconds in men, and less than 470 milliseconds in women, with 1007 unaffected family members. Flat, notched, or negative T-waves in leads II or V5 on baseline ECG were considered abnormal. Using Cox regression analysis, the associations between T-wave morphology, the presence in mutations in the poor region of KCNH2, and the risk of cardiac events defined that syncope aborted cardiac arrest, defibrillator therapy, or sudden cardiac arrests were assessed. The authors found that LQT2 female carriers with abnormal T-wave morphology had a threefold increased risk of cardiac events compared to LQT2 female carriers with normal T-waves, while this association was not seen in males. LQT2 males with poor location of mutations had a six-fold increased risk of cardiac events than non-poor location males, while no such association was found in females. In our last paper, Yaniv Bar-Cohen and associates describe a percutaneous pacemaker entirely implanted in the pericardium, using a sheath for sub-xiphoid access to the pericardial space, and a miniaturized camera with fiber optic illumination, the micro-pacemakers were successfully implanted in six pigs. All animals were studied during follow up, survived without symptoms. That's it for this month. We hope that you'll find the Journal to be the go-to place for everyone interested in the field. See you next time!  

In this episode, Johannes von Alvensleben, MD, pediatric cardiologist and electrophysiologist at Children's Hospital Colorado and assistant professor of pediatrics at the University of Colorado School of Medicine, talks about heart arrhythmias. He discusses some of the most common heart arrhythmias in the primary care setting, including identifiable characteristics and treatments. In this episode: Palpitations and syncope (commonly known as fainting) as symptoms for heart arrhythmia Characteristics of common heart arrhythmias Supraventricular tachycardia (SVT) in an infant versus a young child Differences in children with syncope Inherited heart arrhythmia syndromes Importance of obtaining an electrocardiogram (ECG) Co-morbidities in children that can impact diagnosis with arrhythmias Drug-related arrhythmias in older children Treatment options for heart arrhythmias in young children The success rate of ablation for arrhythmia

This is the fifth podcast in the What are Palpitations? series and it focuses on the most common supraventricular (top-chamber) tachycardias (SVT). We will be discussing a variety of the more common SVT seen in clinical practice and clinical scenarios are used to introduce the listener to these types of arrhythmias.  Arrhythmias discussed include: Premature atrial contractions, AV-node reentrant tachycardia, AV reentrant tachycardia, Atrial tachycardia, Atrial flutter, and Atrial fibrillation (will be discussed in great detail in podcast 6). Please visit www.heart-rhythm-center.com for more information.

This week on Sickboy we sit down with Haley and talk heart stuff, time bombs and the most ideal place to stick a catheter in your body. What is a high heart beat? 150 bpm? 180bpm? Try 260….while sitting still….for 6 hours. For Haley, this is all apart of an episode of Supraventricular Tachycardia, or more boringly referred to as SVT. Having to take drugs that give you the feeling of imminent death and shoving catheters up through your crotch are a just a part of the experience. Join us for an ever-riveting conversation about the absurdity of living illness.

This week on Sickboy we sit down with Haley and talk heart stuff, time bombs and the most ideal place to stick a catheter in your body. What is a high heart beat? 150 bpm? 180bpm? Try 260….while sitting still….for 6 hours. For Haley, this is all apart of an episode of Supraventricular Tachycardia, or more boringly referred to as SVT. Having to take drugs that give you the feeling of imminent death and shoving catheters up through your crotch are a just a part of the experience. Join us for an ever-riveting conversation about the absurdity of living illness.

This week on Sickboy we sit down with Haley and talk heart stuff, time bombs and the most ideal place to stick a catheter in your body. What is a high heart beat? 150 bpm? 180bpm? Try 260….while sitting still….for 6 hours. For Haley, this is all apart of an episode of Supraventricular Tachycardia, or more boringly referred to as SVT. Having to take drugs that give you the feeling of imminent death and shoving catheters up through your crotch are a just a part of the experience. Join us for an ever-riveting conversation about the absurdity of living illness. This episode of Sickboy is brought to you by Hello Fresh. Go to http://www.hellofresh.ca and enter the promo code SICKBOY50 to get 50% of your first box! Video of SVT in action: https://www.youtube.com/watch?v=xVkU8dDSC9w Sickboy is proud to a part of the Antica Podcast Network.

In this episode, Johannes von Alvensleben, MD, pediatric cardiologist and electrophysiologist at Children's Hospital Colorado and assistant professor of pediatrics at the University of Colorado School of Medicine, talks about heart arrhythmias. He discusses some of the most common heart arrhythmias in the primary care setting, including identifiable characteristics and treatments. In this episode: Palpitations and syncope (commonly known as fainting) as symptoms for heart arrhythmia Characteristics of common heart arrhythmias Supraventricular tachycardia (SVT) in an infant versus a young child Differences in children with syncope Inherited heart arrhythmia syndromes Importance of obtaining an electrocardiogram (ECG) Co-morbidities in children that can impact diagnosis with arrhythmias Drug-related arrhythmias in older children Treatment options for heart arrhythmias in young children The success rate of ablation for arrhythmia

After talking about AF, Andy discusses the rest of the supraventricular tachycardias, a topic that can be difficult to understand but very important in critical care settings.

Supraventricular and ventricular tachycardias: risk factors, drugs, and ablation

Supraventricular tachycardias represent a range of tachyarrhythmias originating from a circuit or focus involving the atria or the atrioventricular node. Prompt recognition of the specific type of arrhythmia is essential to determine therapeutic management. Dr. Lior Bibas, cardiology fellow at McGill University in Montréal, Québec, discusses various approaches to treatment. He co-authored a review article published in the CMAJ. Full review article (subscription required): www.cmaj.ca/lookup/doi/10.1503/cmaj.160079 ----------------------------------- Subscribe to CMAJ Podcasts on iTunes, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page. Our podcasts are also released on www.cmaj.ca and on www.cmajblogs.com.

Dr. Hunt through some old school and some new school methods of managing SVT.

Commentary by Dr. Valentin Fuster

NCICU LaGrasta, C Supraventricular Arrhythmias Podcast 123114 by OPENPediatrics

Supraventricular and ventricular arrhythmias

Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial Andrew Appelboam, FRCEM, Adam Reuben, FRCEM, Clifford Mann, FRCEM, James Gagg, FRCEM, Prof Paul Ewings, PhD, Andrew Barton, MSc, Trudie Lobban, MRCP, Mark Dayer, FRCP, Jane Vickery, MSc, Prof Jonathan Benger, MD on behalf of the REVERT trial collaborators The Lancet. 2015; DOI:10.1016/S0140-6736(15)61485-4 Published Online: 24 August 2015 Background: The Valsalva manoeuvre is an internationally recommended treatment for supraventricular tachycardia, but cardioversion is rare in practice (5–20%), necessitating the use of other treatments including adenosine, which patients often find unpleasant. Researchers assessed whether a postural modification to the Valsalva manoeuvre could improve its effectiveness. Methods: The study authors did a randomised controlled, parallel-group trial at emergency departments in England. They randomly allocated adults presenting with supraventricular tachycardia (excluding atrial fi brillation and flutter) in a 1:1 ratio to undergo a modified Valsalva manoeuvre (done semi-recumbent with supine repositioning and passive leg raise immediately after the Valsalva strain), or a standard semi-recumbent Valsalva manoeuvre. A 40 mm Hg pressure, 15 s standardised strain was used in both groups. Randomisation, stratified by centre, was done centrally and independently, with allocation with serially numbered, ...

Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial Andrew Appelboam, FRCEM, Adam Reuben, FRCEM, Clifford Mann, FRCEM, James Gagg, FRCEM, Prof Paul Ewings, PhD, Andrew Barton, MSc, Trudie Lobban, MRCP, Mark Dayer, FRCP, Jane Vickery, MSc, Prof Jonathan Benger, MD on behalf of the REVERT trial collaborators The Lancet. 2015; DOI:10.1016/S0140-6736(15)61485-4 Published Online: 24 August 2015 Background: The Valsalva manoeuvre is an internationally recommended treatment for supraventricular tachycardia, but cardioversion is rare in practice (5–20%), necessitating the use of other treatments including adenosine, which patients often find unpleasant. Researchers assessed whether a postural modification to the Valsalva manoeuvre could improve its effectiveness. Methods: The study authors did a randomised controlled, parallel-group trial at emergency departments in England. They randomly allocated adults presenting with supraventricular tachycardia (excluding atrial fi brillation and flutter) in a 1:1 ratio to undergo a modified Valsalva manoeuvre (done semi-recumbent with supine repositioning and passive leg raise immediately after the Valsalva strain), or a standard semi-recumbent Valsalva manoeuvre. A 40 mm Hg pressure, 15 s standardised strain was used in both groups. Randomisation, stratified by centre, was done centrally and independently, with allocation with serially numbered, ...

Atrial fibrillation, atrial flutter, PSVT, PACs

Richard Clarke and Dr Mark Daniels host a question and answer podcast to answer the questions that you have been kindly sending in. The first question is from a seemingly very healthy person that suffers with a low PE1 (pancreatic elastase) value and poor gut health, Richard and Mark give the person some tips on how to improve their gut health, plus Richard shares the 3 key indicators of a successful healthy life (2:50). Other questions include one from a lady suffering badly with back pain amongst many other problems after a car crash a while ago who wants to get her health back (16:00), a question from a man who wants to know the difference between anabolic steroids and the steroids which are prescribed by doctors (26:30) and the final question is about what Richard and Dr Mark think about Raspberry Ketones (34:00). The other things talked about on the show include vitamin d deficiency, pro-biotics, pre-biotics, plus there was some great feedback from two very happy listeners that have been helped by the answers on the show, chronic injury, co codamol, capsaicin and meditation. Show notes If you want to have your questions answered on the show then you can email Richard in as much detail as possible at: info@richard-clarke.co.uk or contact Dr Mark via info@revolutionaryhealth.co.uk ,you can also contact Richard on twitter or Facebook with your question. If you like the show then please remember to leave your review on iTunes or underneath the podcast on www.richard-clarke.co.uk For more info on gut health go to podcast number 11 with Dr Nigel Plumber Dr Mark mentioned capsaicin cream as the thing that the lady in question 2 should take to relieve pain instead of co codamol. If you want to receive a receive updates from Richard along with some cool free health documents then head over to the blog www.richard-clarke.co.uk and subscribe with your name and email address in the box on the right. 

The discussion of verapamil as an option for the treatment of supraventricular tachycardia (SVT) in RAGE Session Two went off like a fire cracker in the FOAM world. In this RAGEback, Minh Le Cong from the PHARM podcast explains why the RAGE discussion is not going to change his practice, which is to use adenosine as a first line agent. This is followed by a response by RAGErs Karel and Cliff. You — the listener — are left to make up your own mind about which patients (if any) you'll consider verapamil as an option.

Supraventricular - Pfirter Flux - Riaz/Truncate Ratu (Perc Remix) - Tommy Four Seven Drastik (Planetary Assault Systems Remix) - Terence Fixmer Ripper - ExiumLapse - Donor Sevals - Tommy Four Seven Where I Come To Forget - Sigha Armed 3 - Tommy Four Seven Black Hole - Claudio PRC Milgram Experiment - Lucy Sor - Tommy Four Seven Abnormal Distortion - D. Carbone Irradial - Ascion, D. Carbone, Repitch (IT) Consumed (Speedy J Remix) - Gary Beck Avichi (Monoloc Remix) - Emptyset Empty Vessels (Tool 2) - Phil Kieran Backshredding (Forward Strategy Group Remix) - Justin Berkovi